Principal Investigator
- Home
- Dr. Subir Biswas
Dr. Subir Biswas
Principal Investigator
Honors and Recognitions
- Department of Biotechnology (DBT), India – Ramalingaswami Fellowship - 2022
- The American Association of Immunologists (AAI), USA – Trainee Travel Award - 2022
- National Cancer Institute (NCI), National Institutes of Health (NIH), USA – K99 Grant Award - 2021
- Moffitt Cancer Center, Florida, USA – Junior Scientist Research Partnership (JSRP) Grant Award - 2021
- Department of Science & Technology (DST), India – International Travel Grant - 2014
- International Cytokine and Interferon Society (ICIS), USA – Milstein Travel Award - 2014
- Department of Science & Technology (DST), India and Russian Foundation for Basic Research (RFBR), Russia– funded collaborative research exchange visit to Engelhardt Institute of Molecular Biology, Moscow, Russia - 2012
- CSIR-NET (Life Sciences) for PhD Research Fellowship - 2010
- GATE Biotechnology - 2010
Research Interests
- Immunological crosstalk in epithelial malignancies
- Cancer Immunotherapy
- Lymphocytes
- Myeloid cells
- Monoclonal antibodies
RESEARCH
Our research program focuses on understanding the mechanisms governing the balance between protumor and antitumor immune responses in the tumor microenvironment, with an emphasis on the crosstalk between B lymphocytes, T cells & myeloid cells. We aim to design immunotherapeutic interventions that maximize durable protective immunity by exploiting the potential of antitumor antibodies.
Interested about joining Biswas Lab group– send email to sbiswas@actrec.gov.in
Wish to request for sharing research materials– send email to biswas.lab@actrec.gov.in
